Literature DB >> 15490175

Unusual presentation of lupus nephritis.

R Gupta1, N Gulati, A Gupta, A Kumar, A K Dinda, S K Sharma.   

Abstract

We report a male patient who presented with pyrexia, generalized lymphadenopathy, hepatosplenomegaly, and pleural effusion with no cutaneous or musculoskeletal symptoms. Despite extensive investigation, no cause was detected. His initial serology was also negative for autoantibodies. The patient was placed on a trial of antitubercular treatment in view of a positive Mantoux test. His disease evolved into the full clinical picture of systemic lupus erythematosus with nephritis (World Health Organisation class IV) and strongly positive antinuclear antibody and dsDNA over a period of months. He was treated successfully with intravenous cyclophosphamide pulses along with oral prednisolone, and the disease was still in remission after 3 years of follow-up.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15490175     DOI: 10.1007/s00296-004-0478-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   3.580


  11 in total

1.  Progressive hilar and mediastinal lymphadenopathy in systemic lupus erythematosus on corticosteroid therapy.

Authors:  S S Kassan; M L Moss; R L Reddick
Journal:  N Engl J Med       Date:  1976-06-17       Impact factor: 91.245

Review 2.  Castleman's disease.

Authors:  G Palestro; F Turrini; M Pagano; L Chiusa
Journal:  Adv Clin Path       Date:  1999 Jan-Apr

3.  CLINICAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. COMPUTER ANALYSIS OF 520 CASES.

Authors:  E L DUBOIS; D L TUFFANELLI
Journal:  JAMA       Date:  1964-10-12       Impact factor: 56.272

4.  The Lymph Nodes in Disseminated Lupus Erythematosus.

Authors:  R A Fox; P D Rosahn
Journal:  Am J Pathol       Date:  1943-01       Impact factor: 4.307

5.  Incidence of isoniazid-induced antinuclear antibodies in patients of tuberculosis.

Authors:  R Dhand; R Gilhotra; S Sehgal; S K Malik
Journal:  Indian J Med Res       Date:  1987-05       Impact factor: 2.375

6.  Isoniazid induction of antinuclear antibodies. A prospective study.

Authors:  N F Rothfield; W F Bierer; J W Garfield
Journal:  Ann Intern Med       Date:  1978-05       Impact factor: 25.391

7.  Reactive follicular hyperplasia in the lymph node lesions from systemic lupus erythematosus patients: a clinicopathological and immunohistological study of 21 cases.

Authors:  M Kojima; S Nakamura; Y Morishita; H Itoh; K Yoshida; Y Ohno; T Oyama; S Asano; T Joshita; S Mori; T Suchi; N Masawa
Journal:  Pathol Int       Date:  2000-04       Impact factor: 2.534

8.  Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus.

Authors:  R Cervera; M A Khamashta; J Font; G D Sebastiani; A Gil; P Lavilla; I Doménech; A O Aydintug; A Jedryka-Góral; E de Ramón
Journal:  Medicine (Baltimore)       Date:  1993-03       Impact factor: 1.889

9.  Kikuchi's histiocytic necrotizing lymphadenitis: an analysis of 108 cases with emphasis on differential diagnosis.

Authors:  R F Dorfman; G J Berry
Journal:  Semin Diagn Pathol       Date:  1988-11       Impact factor: 3.464

10.  Systemic lupus erythematosus induced by isoniazid.

Authors:  M Salazar-Páramo; R L Rubin; I García-De La Torre
Journal:  Ann Rheum Dis       Date:  1992-09       Impact factor: 19.103

View more
  1 in total

1.  Dosage of X-linked Toll-like receptor 8 determines gender differences in the development of systemic lupus erythematosus.

Authors:  Benjamin R Umiker; Shauna Andersson; Luis Fernandez; Parimal Korgaokar; Amma Larbi; Monika Pilichowska; Craig C Weinkauf; Henry H Wortis; John F Kearney; Thereza Imanishi-Kari
Journal:  Eur J Immunol       Date:  2014-03-20       Impact factor: 5.532

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.